Chief Business Officer, Helsinn Group
PhD in Molecular and Developmental Biology
Georg Buchner is the group chief business officer of Helsinn group, a Swiss fully integrated, global biopharma company with a diversified pipeline of innovative oncology targeted therapies. Georg has over 20 years of experience in business, corporate development and consulting positions. His experience encompasses M&A, private and public fund raising, corporate and business development strategy and product/technology in/out-licencing from preclinical to market stage. In the past worked he worked in various Biotechs and had its own consulting firm, with his involvement spanning start-ups, where he led the sale of Haptogen to Wyeth; to private and public biotechs, including at Amgen INC., where he was the BD responsible for Europe. Georg holds an MBA from the Judge Cambridge University (UK) and a PhD in Molecular and Developmental Biology from Kings College London
